|Series D, 8/06 |
Chevron Technology Ventures
Codexis is a privately held biosciences company applying proprietary synthetic chemistry technologies to create improved versions of small molecule therapeutics. Codexis’ technology enables novel process development solutions for efficient, cost-effective and environmentally friendly pharmaceutical manufacturing. Application of the company’s proprietary protein and strain engineering platform can also generate new intellectual property opportunities for pharmaceutical manufacturers, which may extend the drug product lifecycle. Codexis has more than 15 strategic alliances, and the company’s technology is being applied to the development of more than 20 therapeutic products worldwide. Codexis, Inc. began operations as an independent company in 2002.